Salzhauer Michael’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,135
| Closed | -$200K | – | 92 |
|
|
2026
Q1 | $200K | Buy |
+7,135
| New | +$190K | 0.09% | 73 |
|
|
2024
Q1 | – | Sell |
-1,000
| Closed | -$28.8K | – | 101 |
|
|
2023
Q4 | $28.8K | Buy |
+1,000
| New | +$30.2K | 0.02% | 81 |
|
|
2021
Q4 | – | Sell |
-10
| Closed | – | – | 129 |
|
|
2021
Q3 | $0 | Sell |
10
-4,330
| -100% | -$192K | ﹤0.01% | 139 |
|
|
2021
Q2 | $170K | Hold |
4,340
| – | – | 0.07% | 103 |
|
|
2021
Q1 | $157K | Hold |
4,340
| – | – | 0.08% | 102 |
|
|
2020
Q4 | $159K | Sell |
4,340
-234
| -5% | -$8.58K | 0.11% | 89 |
|
|
2020
Q3 | $159K | Buy |
+4,574
| New | +$160K | 0.18% | 73 |
|
|
2020
Q2 | – | Sell |
-4,564
| Closed | -$141K | – | 96 |
|
|
2020
Q1 | $141K | Sell |
4,564
-1,265
| -22% | -$43.1K | 0.24% | 75 |
|
|
2019
Q4 | $217K | Hold |
5,829
| – | – | 0.1% | 109 |
|
|
2019
Q3 | $199K | Hold |
5,829
| – | – | 0.1% | 111 |
|
|
2019
Q2 | $240K | Hold |
5,829
| – | – | 0.11% | 107 |
|
|
2019
Q1 | $235K | Hold |
5,829
| – | – | 0.12% | 104 |
|
|
2018
Q4 | $241K | Sell |
5,829
-482
| -8% | -$20K | 0.13% | 109 |
|
|
2018
Q3 | $264K | Hold |
6,311
| – | – | 0.1% | 129 |
|
|
2018
Q2 | $217K | Hold |
6,311
| – | – | 0.08% | 146 |
|
|
2018
Q1 | $213K | Hold |
6,311
| – | – | 0.08% | 146 |
|
|
2017
Q4 | $217K | Hold |
6,311
| – | – | 0.09% | 144 |
|
|
2017
Q3 | $214K | Hold |
6,311
| – | – | 0.09% | 139 |
|
|
2017
Q2 | $201K | Hold |
6,311
| – | – | 0.09% | 138 |
|
|
2017
Q1 | $205K | Hold |
6,311
| – | – | 0.1% | 138 |
|
|
2016
Q4 | $194K | Hold |
6,311
| – | – | 0.1% | 136 |
|
|
2016
Q3 | $203K | Sell |
6,311
-13
| -0.2% | -$435 | 0.15% | 116 |
|
|
2016
Q2 | $211K | Hold |
6,324
| – | – | 0.17% | 105 |
|
|
2016
Q1 | $178K | Hold |
6,324
| – | – | 0.15% | 116 |
|
|
2015
Q4 | $194K | Buy |
+6,324
| New | +$199K | 0.14% | 120 |
|
|
2015
Q3 | – | Sell |
-6,324
| Closed | -$203K | – | 155 |
|
|
2015
Q2 | $201K | Hold |
6,324
| – | – | 0.15% | 115 |
|
|
2015
Q1 | $209K | Buy |
+6,324
| New | +$201K | 0.19% | 99 |
|
Other funds holding PFE
Salzhauer Michael's PFE Position: Q2 2026 in Review
Salzhauer Michael sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,135 shares — an estimated $200K sold.
Salzhauer Michael first reported a position in PFE in Q1 2015 and held it in 27 quarters. The position peaked at $264K in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Salzhauer Michael reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Salzhauer Michael sold 7,135 Pfizer shares in Q2 2026, an estimated $200K.
- Salzhauer Michael first reported a position in Pfizer in Q1 2015 and held it in 27 quarters.
- Salzhauer Michael's Pfizer position peaked at $264K in Q3 2018.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Salzhauer Michael's 13F filing for Q2 2026, filed 20 Jul 2026.